建立高靈敏螢光偵測系統以篩選提升類澱粉貝塔蛋白降解酵素生產之化合物

Development of a sensitive fluorescence detection system for high-throughput screening compounds which can promote the production of A

陳柏廷(Po-Ting Chen)

指導教授 ： 王勝仕

國立臺灣大學/工學院/化學工程學研究所/碩士(2009年)

https://doi.org/10.6342/NTU.2009.01256

摘要

類澱粉beta蛋白質(Abeta)是一種生理上的胜肽，由類澱粉前驅蛋白(APP)經一系列代謝途徑所生成，而釋出胞外的Abeta會被許多的內切胜肽酶進行降解代謝，若在腦中的生成與代謝之失衡，則會導致聚集的產生，此為阿茲海默症的成因。阿茲海默症為一種神經退化性疾病，由此可見其發病機制中，Abeta的生成是個十分重要的因素。
對於治療阿茲海默症，清除新生成的Abeta胜肽是可行的策略之一，腦啡肽酶(NEP)被視為清除Abeta的重要內切胜肽酶。在此研究中，我們合成淬滅螢光之胜肽受質來偵測腦啡肽酶的活性，而此胜肽所採用的是Abeta上前七個胺基酸殘基。一螢光分子連接在胜肽的N端，其發出的螢光會被存在於C端半胱氨酸側鏈上的一淬滅分子所消滅。但當此胜肽受質被內切胜肽酶水解，便會放出螢光。而我們實驗的結果也顯示了此檢測系統對於腦啡肽酶(NEP)與胰島素降解酶(IDE)有極高的靈敏性，而對於其他的Abeta降解酶則呈現相當低的靈敏性。此外，基於我們的發現，一套利用細胞進行之檢測系統已建立成形，可用於篩選能夠促進人類神經瘤母細胞上腦啡肽酶產量的藥物。

關鍵字：類澱粉beta蛋白質、Abeta降解酶、腦啡肽酶。

關鍵字

類澱粉貝塔蛋白質 ； 類澱粉貝塔蛋白降解酶腦啡肽酶

並列摘要

Amyloid-b (Ab), a physiological peptide, which is produced from amyloid precursor protein (APP) by sequential cleavages, and released into the extracellular spaces. The released Ab undergoes proteolytic degradation by multiple endopeptidases. The imbalance between the production and catabolism of Ab in the brain results in the accumulation of Ab leading to Alzheimer’s disease. Alzheimer’s disease is a neurodegenerative disease, and Ab in Alzheimer’s disease plays a pivotal role in the pathogenesis of the disease.
Neprilysin (NEP) has been singled out as the most promising candidate in Ab cleaning in the therapeutics of Alzheimer’s disease. In this study, a quenched fluorogenic peptide substrate whose sequence was adopted from the first seven residues of the Ab peptide was synthesized to detect the activity of neprilysin. A fluorophore was attached to the C-terminal Cys residue but its fluorescence was quenched by the existence of a quencher linked to the N-terminus of the peptide. When this peptide substrate was degraded by an endopeptidase, the fluorescence lights up to serve as a sensitive detection system for endopeptidase. Our results showed that this assay system was extremely sensitive to NEP and insulin degrading enzyme (IDE) while inert or much less sensitive to other Ab-degrading enzymes. Moreover, based on our findings, a cell-based assay system was developed to high throughput screen chemicals which are able to enhance NEP and production in human SH-SY5Y cells.

Key words：Amyloid-b, Ab-degrading enzymes, neprilysin

並列關鍵字

Amyloid-beta ； Abeta-degrading enzymes ； neprilysin

參考文獻

56. Miners, J.S., S. Baig, J. Palmer, L.E. Palmer, P.G. Kehoe, and S. Love, A beta-degrading enzymes in Alzheimer's disease. Brain Pathology, 2008. 18(2): p. 240-252.

149. Richard P. Haugland, M.T.Z.S., Iain Johnson, Aaron Basey, The Handbook - A guid to fluorescenct probes and labeling technologies. 2005.

87. Ertekin-Taner, N., J. Ronald, L. Feuk, J. Prince, M. Tucker, L. Younkin, M. Hella, S. Jain, A. Hackett, L. Scanlin, J. Kelly, M. Kihiko-Ehman, M. Neltner, L. Hersh, M. Kindy, W. Markesbery, M. Hutton, M. de Andrade, R.C. Petersen, N. Graff-Radford, S. Estus, A.J. Brookes, and S.G. Younkin, Elevated amyloid beta protein (A beta 42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Human Molecular Genetics, 2005. 14(3): p. 447-460.

47. Qiu, W.Q., D.M. Walsh, Z. Ye, K. Vekrellis, J. Zhang, M.B. Podlisny, M.R. Rosner, A. Safavi, L.B. Hersh, and D.J. Selkoe, Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid beta -Protein by Degradation. The Journal of Biological Chemistry, 1998. 273(49): p. 32730-32738.

42. Weggen, S., J.L. Eriksen, P. Das, S.A. Sagi, R. Wang, C.U. Pietrzik, K.A. Findlay, T.E. Smith, M.P. Murphy, T. Butler, D.E. Kang, N. Marquez-Sterling, T.E. Golde, and E.H. Koo, A subset of NSAIDs lower amyloidogenic A beta 42 independently of cyclooxygenase activity. Nature, 2001. 414(6860): p. 212-216.